Clinical Trial Contract Template for Saudi Arabia

A Clinical Trial Contract is a comprehensive legal agreement that governs the conduct of medical research involving human participants in Saudi Arabia. This document establishes the rights, responsibilities, and obligations of all parties involved in clinical trials, ensuring compliance with strict regulatory requirements and ethical standards mandated by Saudi law.

When do you need this document?

You need a Clinical Trial Contract whenever conducting medical research in Saudi Arabia. This includes Phase I through IV pharmaceutical trials, medical device studies, and biomarker research involving human subjects. The contract is mandatory before recruiting participants and must be executed between sponsors, research institutions, principal investigators, and any contract research organizations. It's also required when establishing relationships with laboratories, insurance providers, and other service providers supporting the trial. International pharmaceutical companies entering the Saudi market particularly need this document to establish compliant research partnerships with local institutions.

Key legal considerations

Several critical legal provisions must be addressed in your Clinical Trial Contract. Informed consent procedures must align with both SFDA requirements and Islamic principles, ensuring participants understand their rights and the voluntary nature of participation. Data protection clauses must comply with Saudi Arabia's Personal Data Protection Law (PDPL), particularly regarding cross-border data transfers and participant privacy. Financial arrangements should clearly define sponsor responsibilities for participant care, adverse event management, and insurance coverage. The contract must establish clear protocols for adverse event reporting to SFDA and include provisions for trial suspension or termination. Intellectual property rights, publication rights, and confidentiality obligations require careful definition to protect all parties' interests while maintaining scientific transparency.

Legal requirements in Saudi Arabia

Saudi Arabia's regulatory framework imposes specific requirements on clinical trial contracts. All trials must receive prior approval from SFDA and relevant Ethics Committees or Institutional Review Boards before commencement. The contract must demonstrate compliance with the Law of Clinical Trials and incorporate SFDA's detailed guidelines on protocol development, safety monitoring, and quality assurance. Principal investigators must hold valid licenses under the Law of Practicing Healthcare Professions and demonstrate adequate qualifications for the specific research area. The contract must address National Committee of Bioethics guidelines, ensuring research conducted respects Saudi cultural and religious values. Insurance provisions must provide adequate coverage for participant injury or adverse events, with clear procedures for compensation. Additionally, the contract must establish mechanisms for ongoing regulatory reporting, inspection compliance, and maintenance of essential trial documentation as required by Saudi authorities.